Notice of Closed Meeting, 26151 [2024-07850]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 73 / Monday, April 15, 2024 / Notices
the 5th Open Government NAP midterm self-assessment report:
• Assessment Clarity and
Comprehensiveness: Feedback on the
clarity and thoroughness of the report
itself in presenting the progress and
challenges encountered during both the
co-creation process and the
implementation process.
• Insights and Learning: Observations
on the lessons and insights derived from
the self-assessment process, including
any areas that may benefit from deeper
analysis.
• Engagement and Inclusivity: Views
of the effectiveness of stakeholder
engagement efforts (including
suggestions for enhancing inclusivity)
during the initial co-creation and the
implementation processes since the
GSA Open Government Secretariat was
stood up in the summer of 2023.
• Utility and Application:
Recommendations on how the Lessons
and Insights of the report can be better
used to inform the remaining
implementation phase and future Open
Government Action Plans.
Resources
Open Government Partnership (OGP)
Independent Review Mechanism (IRM)
Self-Assessment Guidance at https://
www.opengovpartnership.org/wpcontent/uploads/2001/01/OGP_self_
assessment_cal%20FINAL.pdf.
Krystal J. Brumfield,
Associate Administrator, Office of
Government-wide Policy, General Services
Administration.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—RFA–OH–22–002,
NIOSH Centers for Agricultural Safety and
Health.
Date: May 23, 2024.
Time: 1 p.m.–5 p.m., EDT.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Marilyn
Ridenour, B.S.N., M.P.H., Scientific Review
Officer, Office of Extramural Programs,
National Institute for Occupational Safety
and Health, Centers for Disease Control and
Prevention, 1095 Willowdale Road,
Morgantown, West Virginia 26505.
Telephone: (304) 285–5879; Email:
MRidenour@cdc.gov.
The Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention, has been delegated the authority
to sign Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–07850 Filed 4–12–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2024–07900 Filed 4–11–24; 4:15 pm]
Centers for Disease Control and
Prevention
BILLING CODE 6820–UA–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Appointment to the Healthcare
Infection Control Practices Advisory
Committee
Centers for Disease Control and
Prevention
AGENCY:
Notice of Closed Meeting
ddrumheller on DSK120RN23PROD with NOTICES1
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to 5 U.S.C. 1009(d), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, CDC, pursuant to Public Law
92–463. The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
17:44 Apr 12, 2024
Jkt 262001
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), within the
Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Healthcare
Infection Control Practices Advisory
Committee (HICPAC). HICPAC consists
of 14 experts in fields including, but not
limited to, infectious diseases, infection
prevention, healthcare epidemiology,
nursing, clinical and environmental
microbiology, surgery, hospitalist
medicine, internal medicine,
epidemiology, health policy, health
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
26151
services research, public health, and
related fields.
DATES: Nominations for membership on
HICPAC must be received no later than
September 30, 2024. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
emailed to hicpac@cdc.gov; mailed to
HICPAC, Division of Healthcare Quality
Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention, l600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027; or faxed to (404) 639–4043.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., Healthcare
Infection Control Practices Advisory
Committee, Division of Healthcare
Quality Promotion, National Center for
Emerging and Zoonotic Infectious
Diseases, Centers for Disease Control
and Prevention, l600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia
30329–4027. Telephone: (404) 718–
8039; email: hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are sought for individuals
who have the expertise and
qualifications necessary to contribute to
the accomplishment of the objectives of
the Healthcare Infection Control
Practices Advisory Committee
(HICPAC). Nominees will be selected
based on expertise in the fields of
infectious diseases, infection
prevention, healthcare epidemiology,
nursing, clinical and environmental
microbiology, surgery, internal
medicine, occupational health, and
public health. Federal employees will
not be considered for membership.
Members may be invited to serve for up
to four-year terms. Selection of members
is based on candidates’ qualifications to
contribute to the accomplishment of
HICPAC objectives (https://
www.cdc.gov/hicpac/).
Department of Health and Human
Services (HHS) policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on Federal workgroups or
prior experience serving on a Federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
E:\FR\FM\15APN1.SGM
15APN1
]]>Agencies
[Federal Register Volume 89, Number 73 (Monday, April 15, 2024)]
[Notices]
[Page 26151]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-07850]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to 5 U.S.C. 1009(d), notice is hereby given of the
following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Office of
Strategic Business Initiatives, Office of the Chief Operating Officer,
CDC, pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)--RFA-OH-22-002, NIOSH
Centers for Agricultural Safety and Health.
Date: May 23, 2024.
Time: 1 p.m.-5 p.m., EDT.
Place: Video-Assisted Meeting.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Marilyn Ridenour, B.S.N.,
M.P.H., Scientific Review Officer, Office of Extramural Programs,
National Institute for Occupational Safety and Health, Centers for
Disease Control and Prevention, 1095 Willowdale Road, Morgantown,
West Virginia 26505. Telephone: (304) 285-5879; Email:
[email protected].
The Director, Office of Strategic Business Initiatives, Office
of the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal
Register notices pertaining to announcements of meetings and other
committee management activities, for both the Centers for Disease
Control and Prevention and the Agency for Toxic Substances and
Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-07850 Filed 4-12-24; 8:45 am]
BILLING CODE 4163-18-P
